Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome

Bardet-Biedl 综合征视网膜变性的分子病理生理学

基本信息

  • 批准号:
    9235611
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2021-01-31
  • 项目状态:
    已结题

项目摘要

Abstract Mutations disrupting ciliary assembly and trafficking are a common cause of inherited retinal degenerations, causing early-onset severe blindness. Bardet-Biedl syndrome (BBS) is one of the human genetic diseases associated with defective ciliary trafficking and photoreceptor degeneration. However, details of the patho-mechanisms underlying photoreceptor degeneration in BBS are largely unknown and no effective treatment options have been developed. The long-term goal of this research program is to elucidate the molecular and cellular mechanisms of photoreceptor degeneration in BBS and develop therapeutic interventions to preserve vision in BBS patients. Our prior study determined that accumulation of proteins in the outer segment (OS) is likely the primary cause of photoreceptor degeneration in BBS, representing a novel mechanism of photoreceptor degeneration. During the next grant cycle, we will explore how protein accumulation in the OS induces photoreceptor degeneration. Our preliminary data suggest that OS accumulation/sequestration of Stx3 (a SNARE protein facilitating membrane fusion events) and proteasomal overload stress are involved. The proposed study will determine how these factors contribute to photoreceptor degeneration in BBS. The outcome of this study will greatly advance our understanding of the cilia-related retinopathies and provide an important foundation for the development of mechanism-based therapies.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Seongjin Seo其他文献

Seongjin Seo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Seongjin Seo', 18)}}的其他基金

Compartmentalized protein localization in photoreceptors
光感受器中的区室化蛋白质定位
  • 批准号:
    10501525
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Compartmentalized protein localization in photoreceptors
光感受器中的区室化蛋白质定位
  • 批准号:
    10707229
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8918625
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8534137
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8340877
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8708874
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似海外基金

Using a patient-derived fibroblast ciliation assay to perform high throughput drug screen and candidate therapeutic compound validation for Bardet-Biedl syndrome (BBS)
使用患者来源的成纤维细胞纤毛检测对 Bardet-Biedl 综合征 (BBS) 进行高通量药物筛选和候选治疗化合物验证
  • 批准号:
    449358
  • 财政年份:
    2020
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Studentship Programs
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8918625
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8534137
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8340877
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
  • 批准号:
    8708874
  • 财政年份:
    2012
  • 资助金额:
    $ 38.13万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    8146164
  • 财政年份:
    2009
  • 资助金额:
    $ 38.13万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    7753399
  • 财政年份:
    2009
  • 资助金额:
    $ 38.13万
  • 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
  • 批准号:
    7938614
  • 财政年份:
    2009
  • 资助金额:
    $ 38.13万
  • 项目类别:
Small GTPase ARL6 segregates with Bardet-Biedl Syndrome 3 (BBS3) and may be required for cell cycle progession
小 GTP 酶 ARL6 与 Bardet-Biedl 综合征 3 (BBS3) 分离,并且可能是细胞周期进展所必需的
  • 批准号:
    361511-2008
  • 财政年份:
    2008
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Investigating the Genetic Complexity of Bardet-Biedl syndrome (BBS) using the C. elegans Animal Model
使用线虫动物模型研究 Bardet-Biedl 综合征 (BBS) 的遗传复杂性
  • 批准号:
    172205
  • 财政年份:
    2008
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了